U.S. Opioid Prescribing Rate Maps

The data in the maps show the geographic distribution in the United States, at both state and county levels, of retail opioid prescriptions dispensed per 100 persons per year from 2006–2018. 1,2,3,4

Data are displayed within two types of interactive maps that show the estimated rate of opioid prescriptions per 100 U.S. residents. The state maps portray the rates per year for each of the 50 states and the District of Columbia.  The county maps portray these rates for 87.6% to 94.0% of U.S. counties for a given year from 2006-2018.5

Rates are classified by the Jenks6 natural breaks classification method into 4 groups using the 13-year range of data to determine the class breaks. Click on a county or state to reveal its prescription rate or view the corresponding data table for additional information.

Key Highlights

  • After a steady increase in the overall national opioid prescribing rate starting in 2006, the total number of prescriptions dispensed peaked in 2012 at more than 255 million and a prescribing rate of 81.3 prescriptions per 100 persons.
  • The overall national opioid prescribing rate declined from 2012 to 2018, and in 2018, the prescribing rate had fallen to the lowest in the 13 years for which we have data at 51.4 prescriptions per 100 persons (total of more than 168 million total opioid prescriptions).
  • However, in 2018, prescribing rates continue to remain very high in certain areas across the country.
    • In 11% of U.S. counties, enough opioid prescriptions were dispensed for every person to have one.
    • While the overall opioid prescribing rate in 2018 was 51.4 prescriptions per 100 people, some counties had rates that were six times higher than that.
  • Prescribing rates for opioids vary widely across different states and counties. Emerging hotspot areas are identified by the darker colors on the maps.
Table 1. Total number and rate of opioid prescriptions dispensed, United States, 2006–2018
 Year Total Number of
Prescribing Rate
Per 100 Persons
2006 215,917,663 72.4
2007 228,543,773 75.9
2008 237,860,213 78.2
2009 243,738,090 79.5
2010 251,088,904 81.2
2011 252,167,963 80.9
2012 255,207,954 81.3
2013 247,090,443 78.1
2014 240,993,021 75.6
2015 226,819,924 70.6
2016 214,881,622 66.5
2017 191,909,384 59.0
2018 168,158,611 51.4
Table 2. Total number and percentage of counties with available opioid prescribing data, United States, 2006–2018 5
Year Number of Counties
Number of Counties
(with Available Data)
Percentage of Counties
(with Available Data)
2006 3,143 2,754 87.6
2007 3,143 2,746 87.4
2008 3,143 2,758 87.8
2009 3,143 2,750 87.5
2010 3,143 2,741 87.2
2011 3,142 2,745 87.4
2012 3,142 2,736 87.1
2013 3,142 2,753 87.6
2014 3,142 2,960 94.2
2015 3,142 2,963 94.3
2016  3,142 2,962 94.3
2017 3,142 2,955 94.0
2018 3,142 2,881 91.7

Sources and Footnotes

    1. Source for all prescribing data: IQVIA Xponent 2006–2018. IQVIA Xponent is based on a sample of approximately 49,900 retail (non-hospital) pharmacies, which dispense nearly 92% of all retail prescriptions in the United States. For this database, a prescription is an initial or refill prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent. This database does not include mail order prescriptions.
    2. For the calculation of prescribing rates, numerators are the total number of opioid prescriptions dispensed annually at the state, county or national level. Annual resident population denominators were obtained from the U.S. Census Bureau.
    3. Opioid prescriptions, including buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, propoxyphene, tapentadol, and tramadol, were identified using National Drug Codes. All prescriptions with days’ supply between 1 and 365 days and a known strength description were included. Cough and cold formulations containing opioids and buprenorphine products typically used to treat opioid use disorder were not included. In addition, methadone dispensed through methadone treatment programs is not included in the IQVIA Xponent data.
    4. In January 2019 IQVIA changed the frame of measurement in their projected prescription services from reflecting prescription demand to be “number of prescriptions dispensed to bin” to reflecting total prescriptions actually “sold to the patient”.  To do this, IQVIA eliminated the effects of voided and reversed prescriptions (prescriptions that were never received by the patient) beginning in 2017. This change in measurement frame resulted in a 1.9% downward shift in the measured opioid prescriptions dispensed.  This enhancement was applied to data from 2017 and thereafter. Thus, caution should be exercised when examining trends during this time period.
    5. Table 2 displays the percentage of counties in the United States that have opioid prescribing rates available for a given year. A lack of available data may indicate that the county had no retail pharmacies, the county had no retail pharmacies sampled, or the prescription volume was erroneously attributed to an adjacent, more populous county according to the sampling rules used.
    6. Jenks, George F. 1967. “The Data Model Concept in Statistical Mapping,” International Yearbook of Cartography 7: 186–190.

NOTE: These maps display the number of opioid prescriptions per 100 residents, by state and county, from 2006 to 2018. These maps are distinct from the July 2017 issue of CDC Vital Signs, which featured different facets of opioid prescribing from 2006 to 2015, including the amounts of opioids prescribed (morphine milligram equivalents per capita), prescription dosages, and days’ supply, as well as county-level factors associated with increased amounts of opioids prescribed. For more information, visit: https://www.cdc.gov/vitalsigns/opioids/index.html.

Access the latest data. Learn what can be done about overdoseand related harms. CDC VitalSigns